Towards World Models in Biomedical Research
Abstract Overview
This paper is a perspective article that proposes biomedical world models as a new AI paradigm for biomedical research. The authors define these models as systems that learn latent representations of molecular, cellular, tissue, and clinical states together with intervention-conditioned dynamics, so that future trajectories can be simulated before actions are taken. The article situates the concept relative to sensory-space, latent-space, and agent-coupled world models, and discusses the data, representation, dynamics, and agent-design components needed to build such systems. It further outlines applications spanning virtual cells, organoids, virtual patients, and surgical simulation, while emphasizing challenges in data infrastructure, evaluation, privacy, safety, fairness, and deployment.
Novelty
The paper’s distinctive contribution is to frame biomedical research through the lens of world models: multiscale, intervention-aware simulators that support prospective reasoning rather than static pattern recognition. It also extends the world-model concept across molecular to clinical scales and explicitly connects it to scientific discovery agents and closed-loop experimentation.
Results
The article does not report new empirical benchmark results or quantitative performance claims. Its main outcome is a conceptual framework that specifies core properties, design principles, representative use cases, and practical constraints for developing biomedical world models as simulation-guided tools for discovery and decision-making.
Key Points
- Biomedical world models are defined around multiscale latent-state modeling, intervention-aware dynamics, and closed-loop scientific reasoning under partial observability.
- The paper argues that useful implementations will require longitudinal multimodal data, action-conditioned dynamics models, and integration of observable simulations with compact latent planning spaces.
- It identifies promising applications in virtual cells, virtual organoids, virtual patients, and surgical simulation, while highlighting major bottlenecks in datasets, benchmarks, governance, safety, fairness, and scalable deployment.